Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Qualitative in-trial interviews with clinical trial participants are a means of providing rich, in-depth patient experience data to supplement and complement data captured by clinical outcome assessments and other clinical trial efficacy endpoints. Such in-trial interview data can be used to build understanding of disease and treatment experiences, evaluate content validity of clinical outcome assessments, aid interpretation of scores and meaningful changes, inform trial design feasibility and operational considerations, and provide supportive evidence regarding safety, efficacy, and effectiveness. Despite the rapid growth of in-trial interviews as part of clinical development programs in the pharmaceutical industry in recent years, published guidelines regarding the methods, conduct, and implementation of in-trial interviews are scarce. Drawing on published examples and the authors' experiences of conducting in-trial interview studies, this article provides an overview of best practice methods for implementing this methodology (including considerations for study design, sample size, interview conduct, and analysis) and the value of in-trial interview data to answer specific research questions. Operational and logistical considerations are outlined, including recommendations for country selection, site selection, training and communication, adverse event safety reporting, and data management and handling. Well-designed and carefully implemented in-trial interviews can lead to generation of insightful patient experience data that are truly of value to inform regulators, health technology agencies, clinicians, patients, and caregivers about product attributes and the impact of diseases and treatments on patients' lives.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s40271-024-00726-2DOI Listing

Publication Analysis

Top Keywords

in-trial interviews
20
in-trial interview
12
qualitative in-trial
8
best practice
8
interviews clinical
8
clinical trial
8
patient experience
8
experience data
8
clinical outcome
8
outcome assessments
8

Similar Publications

Background: Line managers play a key role in preventing poor mental health but often lack necessary skills and knowledge. Existing interventions typically focus on mental health awareness rather than practical skills. The evidence-based Managing Minds at Work (MMW) web-based training program was developed to address this gap by enhancing line managers' confidence and competence in prevention.

View Article and Find Full Text PDF

Background: The aim of this study was to investigate perspectives on participation in a Group B Streptococcus (GBS) maternal vaccine trial among pregnant women, their partners, family members, friends and other stakeholders in Kampala, Uganda.

Methods: We conducted focus group discussions, in-depth interviews and key informant interviews from October 2022 to February 2023 with 56 participants: 36 pregnant or breastfeeding women, 5 women not in the trial, 5 partners of women in trial, 5 healthcare workers, and 5 community stakeholders. This cross-sectional study was embedded within a GBS maternal vaccine trial conducted at the national referral hospital.

View Article and Find Full Text PDF

Background: Despite the crucial role that randomised controlled trials (RCTs) play in establishing the efficacy of new treatments, many are terminated early due to difficulty with subject recruitment. Trials of complex perioperative interventions are notoriously difficult to deliver. We describe our experiences of successful recruitment into an RCT of anaesthetic technique in vascular access surgery with the aim of exploring barriers and enablers to efficient recruitment and trial delivery.

View Article and Find Full Text PDF

Background: Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematological disease, with symptoms including fatigue, difficulty breathing, and hemoglobinuria, which negatively affect health-related quality of life.

Objective: In-trial interviews with patients with PNH, enrolled across three clinical trials, were conducted to understand patient experiences and satisfaction after receiving iptacopan, a novel treatment for PNH.

Methods: Adult participants with PNH were recruited and consented into the qualitative interviews across three phase II/III iptacopan trials (NCT04558918, NCT04820530, and NCT04747613).

View Article and Find Full Text PDF

Background: Patients with atopic dermatitis (AD) often experience a multitude of interrelated symptoms and impacts linked to the cardinal symptom of itch. Individual patient-reported outcome measures do not on their own reflect the complex physical and psychosocial burden experienced by patients with AD. This manuscript describes a qualitative in-trial interview substudy embedded in a phase 3 trial of nemolizumab in adults and adolescents with moderate-to-severe AD (ClinicalTrials.

View Article and Find Full Text PDF